News search
About the CNIC 23 Nov 2022 |
Research 7 Nov 2022 A CNIC study reveals that mutations previously identified in the gene MINDBOMB1 (MIB1) as causing non-compaction cardiomyopathy either provoke this disease or valve defects, depending on their combination with mutations in modifier genes |
Research 3 Nov 2022 CNIC scientists have identified a molecular mechanism that accounts for the arrhythmias, skeletal muscle weakness, and periodic paralysis in patients with this rare disease |
About the CNIC 2 Nov 2022 A new study defines a mechanism that regulates inflammation after a myocardial infarction, opening a path to the use of the receptor |
Research 18 Oct 2022 A study, published in Nature Metabolism, is the first to demonstrate the key role played by mitochondria in adapting metabolism to different energy demands in humans |
Research 3 Oct 2022 Metoprolol, an established drug in the cardiologists armory, protects the brain during a stroke and greatly reduces its consequences |
About the CNIC 19 Sep 2022 CNIC's leader have been recognized for his exceptional career achievements at the 34th annual conference |
Research 12 Sep 2022 The findings, published in the Journal of the American College of Cardiology (JACC), will enable physicians to make appropriate treatment adjustments for patients with this disease |
Research 29 Aug 2022 The findings, published in the Journal of the American College of Cardiology (JACC), represent a first step towards the personalized treatment of patients with this disease |
Research 26 Aug 2022 The results of the SECURE trial, coordinated by CNIC were presented in a Hot Line session at the European Society of Cardiology meeting (ESC 2022) in Barcelona and published at the NEJM |
- ‹ previous
- 7 of 31
- next ›